108 related articles for article (PubMed ID: 2421131)
1. Differentiation of parenchymal lung disorders with in vitro proton nuclear magnetic resonance.
Vinitski S; Pearson MG; Karlik SJ; Morgan WK; Carey LS; Perkins G; Goto T; Befus D
Magn Reson Med; 1986 Feb; 3(1):120-5. PubMed ID: 2421131
[TBL] [Abstract][Full Text] [Related]
2. Characterization of bleomycin lung injury by nuclear magnetic resonance: correlation between NMR relaxation times and lung water and collagen content.
Cutillo AG; Chan PH; Ailion DC; Watanabe S; Rao NV; Hansen CB; Albertine KH; Laicher G; Durney CH
Magn Reson Med; 2002 Feb; 47(2):246-56. PubMed ID: 11810667
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of alveolitis and pulmonary fibrosis in rabbits with magnetic resonance imaging after intrabronchial administration of bleomycin.
Kersjes W; Hildebrandt G; Cagil H; Schunk K; von Zitzewitz H; Schild H
Invest Radiol; 1999 Jan; 34(1):13-21. PubMed ID: 9888049
[TBL] [Abstract][Full Text] [Related]
4. Proton relaxation times in bleomycin-induced lung injury.
Taylor CR; Sostman HD; Gore JC; Smith GW
Invest Radiol; 1987 Aug; 22(8):621-6. PubMed ID: 2444553
[TBL] [Abstract][Full Text] [Related]
5. Implantation of fetal rat lung fragments into bleomycin-induced pulmonary fibrosis.
Toba H; Sakiyama S; Kenzaki K; Kawakami Y; Uyama K; Bando Y; Tangoku A
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1429-35. PubMed ID: 22305550
[TBL] [Abstract][Full Text] [Related]
6. The effect of pulmonary edema on proton nuclear magnetic resonance relaxation times.
Skalina S; Kundel HL; Wolf G; Marshall B
Invest Radiol; 1984; 19(1):7-9. PubMed ID: 6323345
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent.
Berthezène Y; Vexler V; Kuwatsuru R; Rosenau W; Mühler A; Clément O; Price DC; Brasch RC
Radiology; 1992 Oct; 185(1):97-103. PubMed ID: 1523341
[TBL] [Abstract][Full Text] [Related]
8. In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis.
Jacob RE; Amidan BG; Soelberg J; Minard KR
J Magn Reson Imaging; 2010 May; 31(5):1091-9. PubMed ID: 20432343
[TBL] [Abstract][Full Text] [Related]
9. T2 of endotoxin lung injury with and without methylprednisolone treatment.
Shioya S; Haida M; Tsuji C; Ono Y; Miyairi A; Fukuzaki M; Ohta Y; Yamabayashi H
Magn Reson Med; 1990 Aug; 15(2):201-10. PubMed ID: 2202880
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance relaxation times in acute hydrostatic pulmonary edema induced by noradrenaline in rats.
Shioya S; Tsuji C; Haida M; Fukuzaki M; Tanigaki T; Kurita D; Ohta Y; Yamabayashi H
Lung; 1996; 174(4):235-41. PubMed ID: 8791260
[TBL] [Abstract][Full Text] [Related]
11. [Classification of lung injury by a proton magnetic resonance relaxation process].
Shioya S; Haida M; Ono Y; Ohta Y; Yamabayashi H; Tsuji C; Fukuzaki M
Kokyu To Junkan; 1986 Jul; 34(7):733-40. PubMed ID: 3749631
[No Abstract] [Full Text] [Related]
12. An investigation of possible models for the production of progressive pulmonary fibrosis in the rat. The effects of repeated intratracheal instillation of bleomycin.
Brown RF; Drawbaugh RB; Marrs TC
Toxicology; 1988 Sep; 51(1):101-10. PubMed ID: 2457963
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of lung water by nuclear magnetic resonance imaging. A preliminary study.
Wexler HR; Nicholson RL; Prato FS; Carey LS; Vinitski S; Reese L
Invest Radiol; 1985 Sep; 20(6):583-90. PubMed ID: 4066229
[TBL] [Abstract][Full Text] [Related]
14. Assessment of lung water by magnetic resonance in three types of pulmonary edema.
Vinitski S; Steiner RM; Wexler HR; Rifkin M
Heart Vessels; 1988; 4(2):88-93. PubMed ID: 3253274
[TBL] [Abstract][Full Text] [Related]
15. Effect of bleomycin-induced fibrosis on pulmonary metabolism of selected xenobiotics.
Pillai UA; Schlenk D; Frith C; Ferguson PW
J La State Med Soc; 1994 Jun; 146(6):260-7. PubMed ID: 7520052
[TBL] [Abstract][Full Text] [Related]
16. Acute and repair stage characteristics of magnetic resonance relaxation times in oxygen-induced pulmonary edema.
Shioya S; Haida M; Tsuji C; Ohta Y; Yamabayashi H; Fukuzaki M; Kimula Y
Magn Reson Med; 1988 Dec; 8(4):450-9. PubMed ID: 3231071
[TBL] [Abstract][Full Text] [Related]
17. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats.
Goto T; Befus D; Low R; Bienenstock J
Am Rev Respir Dis; 1984 Nov; 130(5):797-802. PubMed ID: 6208834
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.
Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K
BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819
[TBL] [Abstract][Full Text] [Related]
19. [The comparative study of quartz dust and bleomycin-induced pulmonary fibrosis in rats].
Liu WW; Chen J; Liu YM; Li SM; Yu W; Chen JY; Zhang C; Tang LJ; Lin CL; Zhong XY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Jul; 29(7):496-501. PubMed ID: 22214153
[TBL] [Abstract][Full Text] [Related]
20. Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model.
Milara J; Morcillo E; Monleon D; Tenor H; Cortijo J
PLoS One; 2015; 10(7):e0133453. PubMed ID: 26192616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
